Factors Affecting the Risk of Infection
Microorganisms in Medicine and Therapeutics
Irritable Bowel Syndrome I: Introduction
Fungal Phylum Microsporidia
Surface Membrane Barriers
Defense Mechanism Against Infection
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 7, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Huifen Wang1,2,3, Haiyu Wang1,2,3, Ying Sun1,2,3
1Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
COVID-19 disrupts the gut and lung microbiome, increasing harmful bacteria and decreasing beneficial ones. Restoring this balance with fecal bacteria transplantation, prebiotics, or probiotics may help treat the disease.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: